Global Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global small molecule API market will reach $360.0 billion by 2032, growing by 7.0% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.
Highlighted with 119 tables and 84 figures, this 187-page report "Global Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Region: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire global small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Region.

Based on Source, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Semi-synthetic API
• Natural Origin

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Standard API
• High Potency API (HPAPI)
o Branded HPAPI
o Generic HPAPI

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Clinical Use
• Commercial Use

By Manufacturer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Pharmaceutical Companies
• CMOs

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 28
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter's Fiver Forces Analysis 43
3 Segmentation of Global Market by Source 47
3.1 Market Overview by Source 47
3.2 Synthetic API 49
3.2.1 Branded Synthetic API 50
3.2.2 Generic Synthetic API 51
3.3 Semi-synthetic API 52
3.4 Natural Origin 53
4 Segmentation of Global Market by Product Type 54
4.1 Market Overview by Product Type 54
4.2 Standard API 56
4.3 High Potency API (HPAPI) 57
4.3.1 Branded HPAPI 58
4.3.2 Generic HPAPI 59
5 Segmentation of Global Market by Therapeutic Area 60
5.1 Market Overview by Therapeutic Area 60
5.2 Infectious Diseases 62
5.3 Oncology 63
5.4 Ophthalmology 64
5.5 Cardiovascular Disorders 65
5.6 Central Nervous System 66
5.7 Respiratory Disorders 67
5.8 Metabolic Diseases 68
5.9 Other Therapeutic Areas 69
6 Segmentation of Global Market by Application 70
6.1 Market Overview by Application 70
6.2 Clinical Use 72
6.3 Commercial Use 73
7 Segmentation of Global Market by Manufacturer Type 74
7.1 Market Overview by Manufacturer Type 74
7.2 Pharmaceutical Companies 76
7.3 CMOs 78
8 Segmentation of Global Market by Region 80
8.1 Geographic Market Overview 2022-2032 80
8.2 North America Market 2022-2032 by Country 84
8.2.1 Overview of North America Market 84
8.2.2 U.S. 88
8.2.3 Canada 91
8.2.4 Mexico 93
8.3 European Market 2022-2032 by Country 95
8.3.1 Overview of European Market 95
8.3.2 Germany 99
8.3.3 U.K. 101
8.3.4 France 103
8.3.5 Spain 105
8.3.6 Italy 107
8.3.7 Russia 109
8.3.8 Rest of European Market 111
8.4 Asia-Pacific Market 2022-2032 by Country 113
8.4.1 Overview of Asia-Pacific Market 113
8.4.2 Japan 117
8.4.3 China 120
8.4.4 Australia 122
8.4.5 India 124
8.4.6 South Korea 126
8.4.7 Rest of APAC Region 128
8.5 South America Market 2022-2032 by Country 130
8.5.1 Argentina 133
8.5.2 Brazil 135
8.5.3 Chile 137
8.5.4 Rest of South America Market 139
8.6 MEA Market 2022-2032 by Country 140
8.6.1 UAE 143
8.6.2 Saudi Arabia 145
8.6.3 South Africa 147
8.6.4 Other National Markets 149
9 Competitive Landscape 150
9.1 Overview of Key Vendors 150
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Aurobindo Pharma Ltd. 154
Cambrex Corporation 156
Catalent Inc. 157
Dr. Reddy's Laboratories 160
GlaxoSmithKline plc 163
Lonza Group 167
Merck & Co., Inc. 170
Mylan N.V. 172
Novartis AG 174
Pfizer Inc. 176
Sun Pharmaceutical Industries Ltd. 180
Teva Pharmaceutical Industries Ltd. 183
Wuxi AppTec Co., Ltd. 185
RELATED REPORTS 187

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved